| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Sutro Biopharma, Inc. (STRO) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. STRO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 25.0K | $740.8K | - | |
| Other | 7.9K | $234.8K | - | |
| CFO | 7.5K | $222.2K | - | |
| Other | 7.2K | $213.3K | - | |
| CEO | 5.0K | $148.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 26, 2021 | Hallam Trevor | Chief Scientific Officer | Sale+OE | 2,393 | $25.71 | $61,527.88 | -2.1% | |
| Dec 28, 2020 | Hallam Trevor | Chief Scientific Officer | Sale+OE | 2,393 | $22.37 | $53,530.21 | -6.1% | |
| Nov 27, 2020 | Hallam Trevor | Chief Scientific Officer | Sale+OE | 2,393 | $17.01 | $40,713.07 | -6.1% | |
| Nov 5, 2020 | Hallam Trevor | Chief Scientific Officer | Sale+OE | 16,751 | $15.00 | $251,265.00 | -31.3% | |
| Sep 28, 2020 | Hallam Trevor | Chief Scientific Officer | Sale+OE | 975 | $10.26 | $10,006.72 | -3.4% | |
| Sep 18, 2020 | Freund John Gordon79 | Director | Sell | 400,000 | $12.00 | $4,800,000.00 | -41.7% | |
| Sep 11, 2020 | Freund John Gordon79 | Director | Sell | 500,000 | $10.00 | $5,000,000.00 | -34.2% | |
| Aug 26, 2020 | Hallam Trevor | Chief Scientific Officer | Sell | 975 | $9.04 | $8,818.29 | -5.5% | |
| Aug 19, 2020 | Freund John Gordon79 | Director | Sell | 500,000 | $8.72 | $4,360,000.00 | -25.5% | |
| Jul 27, 2020 | Hallam Trevor | Chief Science Officer | Sell | 975 | $8.06 | $7,858.21 | -5.2% |